On Monday, Shares of Southwest Airlines Co. (NYSE:LUV), gained 2.37% to $37.85, after CEO Gary Kelly said that the airline would cap seating growth expansion at 7%, reversing earlier expectations of 8% growth.
The company formerly said it anticipates seat capacity to grow between 7% and 8% this year, and between 6% and 7% next year.
As a result Southwest also forecast that PRASM, passenger revenue per accessible seat mile, a key indicator of airline profitability, will decline by about 3% year over year this quarter.
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft.
Shares of AbbVie Inc. (NYSE:ABBV), inclined 0.51% to $66.93, during its last trading session.
AbbVie, declared findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with formerly untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers. These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1 in Chicago. Veliparib is an investigational oral poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor being evaluated for the treatment of various cancer types, counting NSCLC.
Lung cancer patients who are current smokers are at a higher risk of death than non-smokers. Tobacco use accounts for at least 30 percent of all cancer deaths, causing 87 percent of lung cancer deaths in men, and 70 percent of lung cancer deaths in women. These data suggest smoking status may influence efficacy for veliparib-chemotherapy combination in advanced NSCLC. A Phase 3 study has been initiated in NSCLC patients with smoking history based on the results seen in the Phase 2 study.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases.
At the end of Monday’s trade, Shares of Eli Lilly and Company (NYSE:LLY), gained 0.13% to $79, hitting its highest level.
Eli Lilly and Company, will attend the Goldman Sachs 36th Annual Global Healthcare Conference on Tuesday, June 9, 2015. Jeffrey Simmons, senior vice president and president, Elanco Animal Health, will take part in a fireside chat at 2:20 p.m., Eastern Daylight Time.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.
Finally, Ericsson (NASDAQ:ERIC), ended its last trade with -0.09% loss, and closed at $11.25.
Ericsson, declared the launch of Ericsson Adaptive Inventory 9.3, redefining inventory administration agility. As operators spend more on software to speed cloud deployments, virtualize network functions and grapple with surging data traffic, Ericsson Adaptive Inventory brings the full visibility and control that operators need to advance networks. This comprises autonomy to build new technologies, capabilities, web-based GUIs and applications.
Ericsson Adaptive Inventory, formerly Ericsson Granite Inventory, uses data from a broad range of accessible sources to offer the most complete view of a network at any given moment, counting past, present and future configurations. The result is faster service rollouts, improved trouble resolution and new network efficiencies as mobile data and IP-centric service delivery becomes more fluid. It features an improved Unified Inventory Engine, intuitive web interface, component-driven design automation, and system extension kit. Ericsson has created a migration path to Ericsson Adaptive Inventory for existing Ericsson Granite Inventory customers.
Ericsson provides communications technology and services worldwide. The company’s Networks segment delivers products and solutions for mobile access, Internet protocol (IP) and transmission networks, core networks, and cloud.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
